Curexo큐렉소
060280 · KOSDAQ · ₩060280 · 큐렉소
₩7,170▼ ₩140 (1.92%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩24B | ₩16B | ₩21B | ₩17B | ₩17B | ₩20B | ₩15B | ₩13B |
| Cost of sales | ₩15B | ₩12B | ₩13B | ₩11B | ₩12B | ₩13B | ₩11B | ₩9.7B |
| Gross profit | ₩8.2B | ₩4.5B | ₩7.6B | ₩6.1B | ₩4.8B | ₩6.3B | ₩4.2B | ₩3.6B |
| Operating income | ₩2.4B | −₩913M | ₩1.4B | ₩341M | −₩205M | ₩843M | −₩1.5B | −₩1.4B |
| Net income | ₩2B | ₩458M | ₩1.9B | ₩1.7B | −₩2B | ₩1.1B | −₩7.2B | −₩125M |
| Net income to shareholders | ₩2.5B | ₩458M | ₩1.9B | ₩621M | −₩890M | ₩1.1B | −₩7.2B | −₩125M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩111B | ₩104B | ₩101B | ₩104B | ₩104B | ₩105B | ₩103B | ₩108B |
| Current assets | ₩97B | ₩89B | ₩87B | ₩90B | ₩90B | ₩91B | ₩88B | ₩91B |
| Cash and equivalents | ₩17B | ₩17B | ₩19B | ₩9.8B | ₩6.4B | ₩3.8B | ₩14B | ₩5.5B |
| Total liabilities | ₩11B | ₩6B | ₩4.9B | ₩9.4B | ₩10B | ₩10B | ₩9.2B | ₩8.9B |
| Current liabilities | ₩9.6B | ₩5.3B | ₩4.2B | ₩8B | ₩8.7B | ₩8.7B | ₩7.9B | ₩7.2B |
| Borrowings | ₩414M | — | — | — | — | — | ₩0 | — |
| Total equity | ₩101B | ₩98B | ₩96B | ₩94B | ₩94B | ₩95B | ₩93B | ₩99B |
| Shareholders' equity | ₩101B | ₩98B | ₩96B | ₩94B | ₩94B | ₩95B | ₩93B | ₩99B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩4.2B | ₩1.6B | −₩3.6B | −₩1.5B | −₩1.4B | −₩4.8B | ₩569M | ₩2.3B |
| Capital spending | ₩119M | ₩84M | ₩1.9B | −₩1.5B | ₩1.8B | ₩201M | ₩2.7B | ₩405M |
| Free cash flow | ₩4.1B | ₩1.5B | −₩5.5B | −₩3B | −₩3.2B | −₩5B | −₩2.1B | ₩1.9B |
Consolidated where available. Amounts in won.
Also known as: Curexo / 큐렉소 / 060280 / KRX:060280
Source: KRX statistical information